Insider Transactions in Q2 2023 at Forte Biosciences, Inc. (FBRX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2023
|
Hubert C Chen Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,593
-34.57%
|
$2,593
$1.01 P/Share
|
|
Apr 01
2023
|
Hubert C Chen Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
-
|
|
Apr 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,241
-14.82%
|
$3,241
$1.01 P/Share
|
|
Apr 01
2023
|
Antony A Riley CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,375
+30.01%
|
-
|
|
Apr 01
2023
|
Paul A. Wagner |
SELL
Payment of exercise price or tax liability
|
Direct |
11,046
-0.78%
|
$11,046
$1.01 P/Share
|
|
Apr 01
2023
|
Paul A. Wagner |
BUY
Exercise of conversion of derivative security
|
Direct |
31,250
+2.17%
|
-
|